Shenzhen Salubris Pharmaceuticals Co.,Ltd.’s Net Profit Rose 20% in 2022

Shenzhen Salubris Pharmaceuticals Co.,Ltd. (深圳信立泰药业股份有限公司) (002294.SZ) reported a net profit of 634.2 million yuan in 2022, up 20% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 13.9% year-on-year.

At the end of the reporting period, it had 9.8 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 18.2%.